Press Release Details

View all news

Quest Diagnostics to Launch Interactive Insights and IntelliTest Interactive Reports and Health Data Analytics Tools at HIMSS 2015

Company's HIT solutions turn health information into actionable insights to help ACOs, health systems, hospitals and physicians improve health care quality, outcomes and efficiencies

MADISON, N.J., April 9, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will unveil a suite of new technology solutions during the HIMSS 2015 Annual Conference & Exhibition, the industry's largest health IT educational program and exhibition, to be held April 13-16 in Chicago (Booth 1280). The new solutions, featuring Interactive Insights™ by Care360® reports and IntelliTest Analytics™, are designed to promote clinically appropriate test selection and tracking of quality and care metrics, among other benefits, to enhance patient care and outcomes for both the individual patient and large managed populations.

Quest Diagnostics Incorporated logo.

"As the leading diagnostic information services provider, providing lab testing and reporting for one in three Americans each year, Quest Diagnostics has unprecedented expertise at collecting, managing and gleaning insights from large-scale health data," said Lidia Fonseca, senior vice president and CIO, Quest Diagnostics. "Now, we are using this expertise to introduce a series of new population health, data analytics and decision support solutions designed to help ACOs, payers, hospitals and physicians glean clinically actionable insights from laboratory and other health data. These solutions help providers select the appropriate test for the patient, adhere to medical guidelines, track quality metrics, and engage patients in health care decision making, promoting better quality and outcomes and lower costs." 

"They reflect Quest's value as a true partner in the diagnostic journey and how we are helping to address the pressing need for greater clarity in diagnostic testing and utilization," Fonseca added. 

Uncertainty and challenges in ordering and interpreting diagnostic laboratory tests potentially affect 23 million patients per year, although improvements in information technology and clinical decision support may reduce physicians' uncertainty, according to a study sponsored by the Centers for Disease Control and Prevention published in the Journal of the American Board of Family Medicine in April 2014.

During the conference, Quest will feature and display several new health care information technology (HIT) products and services, including:

  • Interactive Insights™ by Care360®, a web-based reporting solution for physicians and patients that provides health insights based on a patient's lab data to improve decision making by both the physician and patient. The solution provides lab test results in a graphically rich and interactive format with clinical content, such as related medical guidelines, educational materials and clinical test algorithms, pertinent to the individual patient. With these resources available in a single platform, the physician may be more likely to select appropriate test services guided by a holistic understanding of the patient's individual medical needs. Interactive Insights also provides a simplified graphical view and patient educational materials to help the clinician have a dialogue with the patient to promote engagement in medical decisions. Interactive Insights is available via MyQuest patient portal and Care360 connectivity solutions as well as through designated qualified EHR vendors. Interactive Insights will be showcased at the HIMSS New Product Showcase, located in Exhibit Hall B, across from Booth 8175.
  • IntelliTest Analytics™, a web-based secure portal that provides hospitals, integrated delivery networks, and physician practices with data driven insights about test utilization patterns and business analysis of clinically appropriate testing norms, payer type, and costs. Through the portal, qualifying clients can request a medical consultative review conducted by a Quest Diagnostics medical and scientific expert.
  • MyQuest™ by Care360™®, Quest's patient health portal and mobile solution app. Approximately 1.3 million patients and providers use MyQuest to track lab and other health data and meet Meaningful Use criteria for patient engagement. MyQuest by Care360 features Advanced Access, an interactive tool that allows patients to access and share their laboratory data over several years of testing by Quest Diagnostics in order to track patterns in their health. 
  • Care360 Revenue Cycle Management. More than 250,000 physician and hospital accounts use Quest Diagnostics Care360 connectivity solutions to order and receive laboratory testing and manage related health data.  Care360 Revenue Cycle Management (RCM), the latest offering in the Care360 product portfolio, is a holistic medical billing solution that aids the management of billing claims to denial management with a focus on increasing patient and payer collections and maximizing revenue. Care360 RCM complements and includes the current award-winning cloud-based Care360 Electronic Health Record (EHR) as well as practice management (PM) solutions to support a diverse range of practice, patient, and financial management needs.
  • ChartMaxx® to Complete the Legal Health Record. Quest's award-winning ChartMaxx™ enterprise content management (ECM) solution, used by more than 200 hospitals in the United States and Canada, provides a complete Legal Health Record (LHR), enabling hospitals to manage their most important clinical, business, regulatory and legal records in a secure, accessible format. The solution features a unique tool, intelligent eForms, which helps providers track and manage claims, potentially improving claims billing and minimizing delays. ChartMaxx can connect to multiple EHRs, ERPs and clinical systems within the hospital and across the community to enhance the patient access experience.

Company officials will also be on hand at HIMSS to discuss these and other data analytics tools, now in pilot, that will enable large-scale enterprises, including ACOs, large physician practices and hospital systems, to manage health, financial and other data more effectively to improve quality and cost efficiencies. During the conference, Quest will also hold a series of educational "Tech Talks" by executives and industry thought leaders on advances in technology and information management, as well as Quest solutions that are helping health care providers and organizations provide better care and value across care settings.

For the schedule for Quest's HIMSS 2015 "Tech Talks":

To learn more about what Quest HIT solutions to be on display at HIMSS:

HIMSS is a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause.  HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services needed to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at Follow us at and

Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.

Wendy Bost, Quest Diagnostics (Media): 973-520-2800 
Jenny Dudikoff, K P (Media at HIMSS): 916-224-9429
Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900



To view the original version on PR Newswire, visit:

SOURCE Quest Diagnostics

Categories: Press Releases
View all news